Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
B. longum 1714 vs Probiotics: Probiotics has the stronger overall evidence (9 vs 3/10); they're alternatives for support mood — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Probiotics wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Likely helps
23 of 30 studies with measurable effects showed benefit.
Top outcomes
1 x 10^9 to 1 x 10^10 CFU daily — the two trials that state a dose used 1 x 10^10 CFU/day (depression) and a minimum of 1 x 10^9 CFU/day (pregnancy). Neither found a benefit on its primary endpoint, so this is the dose range that has been tested, not a dose shown to work.
any
Freeze-dried capsule or sachet standardized to B. longum 1714
10-20 billion CFU
With or without food (strain-dependent), Same time daily for consistency
Capsules with multiple strains
Redundant rather than harmful, and the strain-level claims are weak: the two largest trials both missed their primary endpoints and every objective measurement taken (actigraphy, behavioural testing) was null.
Choose one. Do not expect a generic blend to reproduce this strain's research, or this strain to deliver gut benefits it has never been tested for.
4 weeks
8 weeks
n/a
n/a
2-4 weeks
4-8 weeks
4-8 weeks
First 1-2 weeks
Effects of Bifidobacterium longum 1714 on low mood and related symptoms: A randomized, double-blind, placebo-controlled trial.
Exp Clin Psychopharmacol (2026) · Rct · n=168
PRIMARY ENDPOINT MISSED: BDI-II change vs placebo was -0.303 (95% CI -1.957 to 1.35, p=.718) at week 4 and -1.432 (95% CI -3.30 to 0.44, p=.132) at week 8
Bifidobacterium longum 1714 improves sleep quality and aspects of well-being in healthy adults: a randomized, double-blind, placebo-controlled clinical trial.
Sci Rep (2024) · Rct · n=89
PRIMARY ENDPOINT MISSED: PSQI global score improved in both groups, with no significant advantage for the strain
Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers.
Transl Psychiatry (2016) · Pilot · n=22
PubMed classifies this as a Controlled Clinical Trial, NOT a Randomized Controlled Trial
Preventive Effect of Probiotics on Oral Mucositis Induced by Cancer Treatment: A Systematic Review and Meta-Analysis
International journal of molecular sciences (2022) · Meta analysis · n=708
Three trials using Lactobacilli-based probiotics reported that the incidence of oral mucositis in the probiotic group was significantly low (risk ratio [RR] = 0.84, 95% confidence interval [CI] = 0.77−0.93, p = 0.0004).
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
Probiotics for the prevention of Clostridioides difficile-associated diarrhea in adults and children.
The Cochrane database of systematic reviews (2025) · Meta analysis · n=9955
Probiotics may prevent CDAD: NNTB 65 (95% CI 48 to 97)
Based on meta-analyses showing benefits for IBS and digestive symptoms. Effect sizes varied considerably between studies with low to very low certainty of evidence. Initial GI symptoms common when starting but typically resolve within 1-2 weeks.
AI-estimated from published studies. Interpret as directional guidance.
Probiotics has a higher evidence score (9/10 vs 3/10) and wins in 2 of 3 categories.
For support mood, Probiotics has a higher relevance score (60 vs 20).
Redundant rather than harmful, and the strain-level claims are weak: the two largest trials both missed their primary endpoints and every objective measurement taken (actigraphy, behavioural testing) was null. Choose one. Do not expect a generic blend to reproduce this strain's research, or this strain to deliver gut benefits it has never been tested for. Consult a healthcare provider for personalized advice.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Saffron, EPA omega-3, SAMe have real adjunct evidence — but these aren’t a substitute for care, and some interact dangerously.
Probiotics vs prebiotics vs synbiotics, the CFU myth, and what actually helps bloating.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.